https://geneonline.news/泛ras抑制劑adc成癌症治療新希望/2026-05-04T00:14:10.000Zweekly0.8 https://geneonline.news/tortugas獲創投注資推進神經學藥物開發/2026-05-04T00:14:03.000Zweekly0.8 https://geneonline.news/中國細胞療法一期臨床試驗領先全球/2026-05-04T00:13:57.000Zweekly0.8 https://geneonline.news/生技併購里程碑付款成常態/2026-05-04T00:13:49.000Zweekly0.8 https://geneonline.news/川普政府決策模式引憂-小型生技公司恐受衝擊/2026-05-04T00:13:43.000Zweekly0.8 https://geneonline.news/禿髮數據亮眼-nektar-生技募資成功-first-tracks-bio-納斯達克上市/2026-05-04T00:13:39.000Zweekly0.8 https://geneonline.news/賽諾菲btk抑制劑歐盟報喜-美國受挫/2026-05-04T00:13:33.000Zweekly0.8 https://geneonline.news/inventiva高層重組迎接關鍵數據發布/2026-05-04T00:13:27.000Zweekly0.8 https://geneonline.news/oruka乾癬新藥二期數據亮眼長期療效待驗證/2026-05-04T00:13:20.000Zweekly0.8 https://geneonline.news/aacr會議聚焦新靶點生物製藥併購活躍kurma基金引關注/2026-05-04T00:13:14.000Zweekly0.8 https://geneonline.news/aacr大會揭示腫瘤治療新靶點-2/2026-05-04T00:13:08.000Zweekly0.8 https://geneonline.news/intellia體內基因編輯技術後期試驗成功-市場接受度成關/2026-05-04T00:13:02.000Zweekly0.8 https://geneonline.news/禮來併購ajax擴張產品線-sun-pharmaceutical收購organon擴大市佔/2026-05-04T00:12:55.000Zweekly0.8 https://geneonline.news/美國癌症研究協會發現172個癌症治療新標靶/2026-05-04T00:12:48.000Zweekly0.8 https://geneonline.news/歐洲創投kurma募資逾兩億歐元聚焦早期公司創建/2026-05-04T00:12:42.000Zweekly0.8 https://geneonline.news/aurora客製化鹼基編輯技術獲千萬美元融資-瞄準苯丙酮/2026-05-04T00:12:36.000Zweekly0.8 https://geneonline.news/罕見兒科疾病優先審查憑證價格居高不下-3/2026-05-04T00:12:31.000Zweekly0.8 https://geneonline.news/teva製藥七億美元收購emalex-擴大兒童神經疾病治療佈局/2026-05-04T00:12:26.000Zweekly0.8 https://geneonline.news/義大利藥廠chiesi斥資19億美元收購kalvista擴大罕見疾病產品/2026-05-04T00:12:18.000Zweekly0.8 https://geneonline.news/罕見疾病藥物審查受阻-小生技公司槓上fda/2026-05-04T00:12:13.000Zweekly0.8 https://geneonline.news/生物世紀聚焦降低car-t細胞免疫原性及唐氏症bach1研究/2026-05-04T00:12:04.000Zweekly0.8 https://geneonline.news/scala-biodesign完成a輪融資加速ai生物製劑平台擴張/2026-05-04T00:11:57.000Zweekly0.8 https://geneonline.news/自體免疫疾病治療新曙光-自體免疫t細胞銜接器嶄露/2026-05-04T00:11:52.000Zweekly0.8 https://geneonline.news/歐洲創投forbion放眼亞洲尋找生技新標的/2026-05-04T00:11:45.000Zweekly0.8 https://geneonline.news/雙有效載荷抗體藥物複合體有望成癌症治療新趨勢/2026-05-04T00:11:38.000Zweekly0.8 https://geneonline.news/肥胖療法公司kailera擴大ipo規模/2026-05-04T00:11:31.000Zweekly0.8 https://geneonline.news/生物技術產業持續升溫-coultreon獲巨額融資/2026-05-04T00:11:24.000Zweekly0.8 https://geneonline.news/syncona投資策略轉向-強調因果生物學應用/2026-05-04T00:11:18.000Zweekly0.8 https://geneonline.news/前銀行家揭露fda內部運作：謹慎獨立保障公眾健康/2026-05-04T00:11:13.000Zweekly0.8 https://geneonline.news/腦白質退化症藥物開發藍圖出爐/2026-05-04T00:11:07.000Zweekly0.8 https://geneonline.news/生技公司ipo熱潮湧現，數據驅動募資成趨勢/2026-05-04T00:11:01.000Zweekly0.8 https://geneonline.news/美國擬禁採中國臨床試驗數據應對生物醫藥競爭/2026-05-04T00:10:56.000Zweekly0.8 https://geneonline.news/基因體學先驅凡特逝世享壽八十歲/2026-05-04T00:10:50.000Zweekly0.8 https://geneonline.news/structure任命lang為營運長兼總法律顧問/2026-05-04T00:10:43.000Zweekly0.8 https://geneonline.news/neomorph完成一億美元b輪募資加速癌症新藥開發/2026-05-04T00:10:35.000Zweekly0.8 https://geneonline.news/印度太陽藥業百億美元收購organon/2026-05-04T00:10:26.000Zweekly0.8 https://geneonline.news/諾華兩項療法獲歐盟批准-慢性蕁麻疹與瘧疾治療現/2026-05-04T00:10:20.000Zweekly0.8 https://geneonline.news/阿斯特捷利康狼瘡新藥獲美fda批准-患者可自行注射/2026-05-04T00:10:14.000Zweekly0.8 https://geneonline.news/biomarin斥資48億美元收購amicus擴大罕病藥物組合/2026-05-04T00:10:08.000Zweekly0.8 https://geneonline.news/rocket-pharmaceuticals出售優先審查憑證獲利1-8億美元/2026-05-04T00:10:02.000Zweekly0.8 https://geneonline.news/arcera與復星集團合作推動神經科學創新/2026-05-04T00:09:56.000Zweekly0.8 https://geneonline.news/再生元公司第一季淨利下滑非通用會計準則下仍增/2026-05-04T00:09:51.000Zweekly0.8 https://geneonline.news/ray-therapeutics基因療法獲歐盟ema優先藥物資格認定/2026-05-04T00:09:46.000Zweekly0.8 https://geneonline.news/leo-pharma收購replay強化基因療法實力/2026-05-04T00:09:41.000Zweekly0.8 https://geneonline.news/fda批准auvelity上市治療阿茲海默症躁動-2/2026-05-04T00:09:37.000Zweekly0.8 https://geneonline.news/glp1藥物法規政策高峰會探討市場挑戰/2026-05-04T00:09:31.000Zweekly0.8 https://geneonline.news/美國fda加強胜肽藥物監管/2026-05-04T00:09:25.000Zweekly0.8 https://geneonline.news/藥品回收與安全丟棄：現況挑戰與未來趨勢/2026-05-04T00:09:18.000Zweekly0.8 https://geneonline.news/fda加強胜肽藥品監管-調劑業者面臨合規挑戰/2026-05-04T00:09:12.000Zweekly0.8 https://geneonline.news/美國司法部新政策-強化藥品食品企業合規責任/2026-05-04T00:09:05.000Zweekly0.8 https://geneonline.news/fda重申臨床試驗報告義務-確保資訊透明度/2026-05-04T00:09:01.000Zweekly0.8 https://geneonline.news/快速診斷技術崛起-監管挑戰與創新/2026-05-04T00:08:56.000Zweekly0.8 https://geneonline.news/fda完全回覆信函爭議再起-公民請願挑戰監管權威/2026-05-04T00:08:50.000Zweekly0.8 https://geneonline.news/美國大麻產業監管現況與未來展望/2026-05-04T00:08:43.000Zweekly0.8 https://geneonline.news/fda公布未遵守藥品申報企業名單/2026-05-04T00:08:37.000Zweekly0.8 https://geneonline.news/樞紐中心模式面臨轉型-適應性與共享策略成關鍵/2026-05-04T00:08:31.000Zweekly0.8 https://geneonline.news/藥品福利管理機構產業趨勢線上研討會/2026-05-04T00:08:25.000Zweekly0.8 https://geneonline.news/藥廠如何應對醫療成本高漲挑戰：重塑共同支付援/2026-05-04T00:08:19.000Zweekly0.8 https://geneonline.news/美國藥局營收創新高-glp1藥物需求激增成主因/2026-05-04T00:08:13.000Zweekly0.8 https://geneonline.news/醫療福利最大化機構崛起藥廠面臨新挑戰-4/2026-05-04T00:08:07.000Zweekly0.8 https://geneonline.news/美國藥局與藥品福利管理機構2026年經濟報告發布-5/2026-05-04T00:08:02.000Zweekly0.8 https://geneonline.news/藥品通路領導論壇落幕聚焦產業發展/2026-05-04T00:07:55.000Zweekly0.8 https://geneonline.news/罕見疾病藥局模式需重新思考-以患者為中心提供精/2026-05-04T00:07:50.000Zweekly0.8 https://geneonline.news/美國藥品福利管理機構市場三大巨頭持續主導-2/2026-05-04T00:07:45.000Zweekly0.8 https://geneonline.news/藥品通路新聞總覽：信諾整合、默克藥價、沃爾格/2026-05-04T00:07:38.000Zweekly0.8 https://geneonline.news/covermymeds舉辦創新圓桌會議探討患者藥品可及性/2026-05-04T00:07:29.000Zweekly0.8 https://geneonline.news/美國藥品福利管理機構面臨市場變革-2026年處方集排/2026-05-04T00:07:23.000Zweekly0.8 https://geneonline.news/藥品通路新專欄解析醫療成本與定價亂象/2026-05-04T00:07:21.000Zweekly0.8 https://geneonline.news/降低通膨法案衝擊藥局利潤-藥品降價成雙面刃/2026-05-04T00:07:18.000Zweekly0.8 https://geneonline.news/美國聯邦貿易委員會重塑藥品通路-express-scripts和解協議引/2026-05-04T00:07:11.000Zweekly0.8 https://geneonline.news/美國藥品通路掀起淨價革命/2026-05-04T00:07:02.000Zweekly0.8 https://geneonline.news/美國藥品定價合約策略峰會聚焦產業變革/2026-05-04T00:06:54.000Zweekly0.8 https://geneonline.news/美國藥品通路垂直整合現況與未來挑戰報告出爐/2026-05-04T00:06:46.000Zweekly0.8 https://geneonline.news/患者支援計畫轉移風險與最佳實踐/2026-05-04T00:06:40.000Zweekly0.8 https://geneonline.news/ai助力特種療法-crm提升病患服務/2026-05-04T00:06:37.000Zweekly0.8 https://geneonline.news/特殊藥房市場集中度高-pbm關聯企業佔主導地位/2026-05-04T00:06:30.000Zweekly0.8 https://geneonline.news/藥廠轉型直達消費者模式-整合定價需求配送擴大藥/2026-05-04T00:06:19.000Zweekly0.8 https://geneonline.news/藥品通路新聞綜述：pbm專科藥房體驗、利潤轉移、/2026-05-04T00:06:12.000Zweekly0.8 https://geneonline.news/藥廠毛利淨利壓力大增-即時監控與干預成關鍵/2026-05-04T00:06:04.000Zweekly0.8 https://geneonline.news/歐盟聯合臨床評估系統面臨挑戰-首份報告發布在-2/2026-05-04T00:05:58.000Zweekly0.8 https://geneonline.news/梯瓦製藥九億美元收購emalex擴大後期產品線/2026-05-04T00:05:52.000Zweekly0.8 https://geneonline.news/奇亞埃斯製藥斥資十九億美元收購kalvista擴展罕病產品/2026-05-04T00:05:46.000Zweekly0.8 https://geneonline.news/抗凝血藥專利到期-藥廠面臨百億美元營收挑戰/2026-05-04T00:05:40.000Zweekly0.8 https://geneonline.news/leo-pharma收購replay強化罕見皮膚病基因療法研發/2026-05-04T00:05:35.000Zweekly0.8 https://geneonline.news/百時美施貴寶押寶新藥-milvexian-與-cobenfy-臨床數據將定未來/2026-05-04T00:05:29.000Zweekly0.8 https://geneonline.news/禮來減重藥物需求強勁-上調2026年營收預期/2026-05-04T00:05:23.000Zweekly0.8 https://geneonline.news/fda批准auvelity治療阿茲海默症躁動-4/2026-05-04T00:05:18.000Zweekly0.8 https://geneonline.news/沙烏地阿拉伯崛起成中東臨床試驗新興市場/2026-05-04T00:05:12.000Zweekly0.8 https://geneonline.news/技術碎片化推高臨床試驗成本-統一數據管理成解-2/2026-05-04T00:05:07.000Zweekly0.8 https://geneonline.news/alvarez-marsal任命nitin-lath為印度企業財務董事總經理-2/2026-05-04T00:05:03.000Zweekly0.8 https://geneonline.news/印度藥廠akums推出新注射劑對抗多重抗藥性感染/2026-05-04T00:04:58.000Zweekly0.8 https://geneonline.news/眼科研討會聚焦臨床轉化-產學研合作共築創新生態/2026-05-04T00:04:52.000Zweekly0.8 https://geneonline.news/印度製藥博覽會2027塑造產業未來/2026-05-04T00:04:46.000Zweekly0.8 https://geneonline.news/印度瑞迪博士實驗室糖尿病學名藥獲准在加拿大上/2026-05-04T00:04:40.000Zweekly0.8 https://geneonline.news/印度藥品監管機構將舉辦who-gmp及copp網路研討會/2026-05-04T00:04:36.000Zweekly0.8 https://geneonline.news/parexel收購vitrana強化ai藥物警戒能力-3/2026-05-04T00:04:30.000Zweekly0.8 https://geneonline.news/太陽製藥出售罕見兒科疾病優先審查憑證獲利近兩/2026-05-04T00:04:24.000Zweekly0.8 https://geneonline.news/禮來公司力挺印度打擊偽藥-提供辨識指南保障民眾/2026-05-04T00:04:19.000Zweekly0.8 https://geneonline.news/印度製藥產業崛起-挑戰與潛力並存/2026-05-04T00:04:14.000Zweekly0.8 https://geneonline.news/輝瑞braftovi聯合療法獲fda完全批准用於治療braf-v600e突變轉移/2026-05-04T00:04:08.000Zweekly0.8